Joseph Cappello - Dec 16, 2024 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
VP, Pharmaceutical Development
Signature
/s/ Sean Ryder, Attorney-in-Fact
Stock symbol
GNLX
Transactions as of
Dec 16, 2024
Transactions value $
-$14,742
Form type
4
Date filed
12/18/2024, 04:35 PM
Previous filing
Jul 8, 2024
Next filing
Dec 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNLX Common Stock Sale -$14.7K -6.3K -30.07% $2.34 14.7K Dec 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.